Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 23, 2026

1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks

View original at finance.yahoo.com
1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks There's no doubt that artificial intelligence (AI) stocks have been the talk of the stock market for the past few years…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Training and running AI models require lots of computing power, data storage, and networking, mostly supplied by major cloud platforms

    60% confidence

  • VGT is not ideal for AI exposure because it excludes major AI companies in other sectors

    60% confidence

  • Artificial intelligence stocks have been the talk of the stock market for the past few years

    60% confidence

  • Now is not the time to jump ship on AI stocks despite slow start to 2026

    60% confidence

  • AWS is the largest cloud platform in the world and thousands of businesses rely on it for daily operations

    60% confidence

Data points we hold from this source

Apple Podcasts · etf weight14.33 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks — Source | Via News | ViaNews Market